animal disease models

Summary

Summary: Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.

Webpages

  1. disease models, animal
    lib.bioinfo.pl/meid:2210
  2. disease models, animal
    buchta.lib.bioinfo.pl/meid:2210
  3. pcbe: transcripts (july 24, 2003): session 3
    www.bioethics.gov/transcripts/july03/session3.html
  4. ohio university, ecology and evolutionary biology - faculty
    www.biosci.ohiou.edu/grad/micro/faculty.htm
  5. bionomics - technology
    www.bionomics.com.au/page.php?section=116
  6. phylonix - zebrafish assays for drug screening - partnerships
    www.phylonix.com/partnerships.htm
  7. disease models, animal
    dogs.lib.bioinfo.pl/meid:2210

Research Grants

  1. Molecular Genetics Of Heritable Human Disorders
    JANICE CHOU; Fiscal Year: 2006
  2. Heterologous abs from llama and chicken egg yolk to prevent rotavirus diarrhea
    LINDA J saif2@osuedu PROFESSOR SAIF; Fiscal Year: 2009
  3. Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing
    GEORGE NORBERT COX; Fiscal Year: 2008
  4. Long Acting VEGF Binding Proteins for Treating Rheumatoid Arthritis
    GEORGE NORBERT COX; Fiscal Year: 2008
  5. Long Acting VEGF Binding Proteins for Treating Rheumatoid Arthritis
    GEORGE NORBERT COX; Fiscal Year: 2007
  6. Imaging Cytolytic T Cells in Cancer Patients Using PET Reporter Genes/Reporter Pr
    Sanjiv S Gambhir; Fiscal Year: 2008
  7. In vivo RNAi nanoparticle cancer gene function reagent
    Martin C Woodle; Fiscal Year: 2008
  8. Improved in vivo delivery of siRNA
    Lance P Ford; Fiscal Year: 2008
  9. Training Program in Developmental Biology
    Victoria E Prince; Fiscal Year: 2008
  10. BIOCHEMISTRY AND FUNCTION OF NOVEL MONOKINES
    BARBARA A SHERRY; Fiscal Year: 2002

Publications

  1. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease
    Takao Yasuhara
    Department of Neurological Surgery, Okayama University, Graduate School of Medicine and Dentistry, Okayama, Japan
    Eur J Neurosci 19:1494-504
  2. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity
    Akira Nakajima
    Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466 8560, Japan
    J Neurosci 24:2212-25
  3. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
    Tara Karnezis
    Neuroimmunology Laboratory, Department of Biochemistry, School of Molecular Sciences, La Trobe University, Bundoora, Victoria 3086, Australia
    Nat Neurosci 7:736-44
  4. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833
    Garth T Whiteside
    Purdue Pharma Discovery Research, 6 Cedar Brook Drive, Cranbury, NJ 08512, USA
    Eur J Pharmacol 528:65-72
  5. Responses of transgenic mouse lines p53(+/-) and Tg.AC to agents tested in conventional carcinogenicity bioassays
    J W Spalding
    National Institute of Environmental Health Sciences, Laboratory of Environmental Carcinogenesis and Mutagenesis, Research Triangle Park, North Carolina 27709, USA
    Toxicol Sci 53:213-23
  6. Opposing effects of cyclooxygenase-2 selective inhibitors on oxygen-glucose deprivation-induced neurotoxicity
    Tania F Gendron
    Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada K1H 8M5
    Eur J Pharmacol 493:45-55
  7. Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline
    Sylvie Cornet
    IPSEN: Institut Henri Beaufour, 5 Avenue du Canada, 91966 Les Ulis, France
    Eur J Pharmacol 505:111-9
  8. Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice
    Michael Schroeter
    Department of Neurology, Heinrich-Heine-University, Moorenstrasse 5, D-40225 Düsseldorf, Germany
    Brain Res Mol Brain Res 117:1-7
  9. Dual effect of local application of nitric oxide donors in a model of incision pain in rats
    Wiliam A Prado
    Department of Pharmacology, Faculty of Medicine of Ribeirão Preto USP, Av Bandeirantes 3900, CEP 14049 900, Ribeirão Preto, São Paolo, Brazil
    Eur J Pharmacol 441:57-65
  10. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies
    Richard Kirsch
    Department of Anatomical Pathology, University of Cape Town, Cape Town, Western Cape, South Africa
    J Gastroenterol Hepatol 18:1272-82

Scientific Experts

Detail Information

Webpages7

  1. disease models, animal
    lib.bioinfo.pl/meid:2210
  2. disease models, animal
    buchta.lib.bioinfo.pl/meid:2210
  3. pcbe: transcripts (july 24, 2003): session 3
    www.bioethics.gov/transcripts/july03/session3.html
  4. ohio university, ecology and evolutionary biology - faculty
    www.biosci.ohiou.edu/grad/micro/faculty.htm
  5. bionomics - technology
    www.bionomics.com.au/page.php?section=116
  6. phylonix - zebrafish assays for drug screening - partnerships
    www.phylonix.com/partnerships.htm
  7. disease models, animal
    dogs.lib.bioinfo.pl/meid:2210

Research Grants26

  1. Molecular Genetics Of Heritable Human Disorders
    JANICE CHOU; Fiscal Year: 2006
    ..Recent development of animal disease models now opens the opportunity to delineate the disease more precisely and develop therapies targeting the ..
  2. Heterologous abs from llama and chicken egg yolk to prevent rotavirus diarrhea
    LINDA J saif2@osuedu PROFESSOR SAIF; Fiscal Year: 2009
    ..Saif's lab to learn newer immunologic procedures (flow cytometry, etc) and work with specialized animal disease models (Gn pigs) as well as to enhance analytical skills related to mucosal immunity...
  3. Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing
    GEORGE NORBERT COX; Fiscal Year: 2008
    ..interferon analogs that are significantly more efficacious than a leading commercial beta interferon in animal disease models. The goals of this Phase II continuing renewal proposal are to manufacture the protein under GLP (Good ..
  4. Long Acting VEGF Binding Proteins for Treating Rheumatoid Arthritis
    GEORGE NORBERT COX; Fiscal Year: 2008
    ..manufacturing process and produce sufficient quantities of PEGylated recombinant sFlt-1 for testing in animal disease models of RA...
  5. Long Acting VEGF Binding Proteins for Treating Rheumatoid Arthritis
    GEORGE NORBERT COX; Fiscal Year: 2007
    ..manufacturing process and produce sufficient quantities of PEGylated recombinant sFlt-1 for testing in animal disease models of RA...
  6. Imaging Cytolytic T Cells in Cancer Patients Using PET Reporter Genes/Reporter Pr
    Sanjiv S Gambhir; Fiscal Year: 2008
    ..PRP) can be used for long-term monitoring of ex-vivo genetically engineered therapeutic cells in small animal disease models and then in human patients...
  7. In vivo RNAi nanoparticle cancer gene function reagent
    Martin C Woodle; Fiscal Year: 2008
    ..has been confined largely to cell culture studies, with limited methods for in vivo administration in animal disease models such as NSCLC xenograft tumor models, and none available as a research reagent...
  8. Improved in vivo delivery of siRNA
    Lance P Ford; Fiscal Year: 2008
    ..As a result of this success, the therapeutic potential of siRNA is being actively investigated in animal disease models and in humans...
  9. Training Program in Developmental Biology
    Victoria E Prince; Fiscal Year: 2008
    ..Developmental biology studies at the University of Chicago include the generation of animal disease models, studies of cancer and stem cell biology, as well as research into the underlying basis of birth defects ..
  10. BIOCHEMISTRY AND FUNCTION OF NOVEL MONOKINES
    BARBARA A SHERRY; Fiscal Year: 2002
    ..to many inflammatory stimuli, and that there is differential control of these molecules in several animal disease models. This control is critical because inflammatory reactions that are disproportionate to the magnitude of the ..
  11. Long-Acting Beta Interferon for Multiple Scierosis
    GEORGE NORBERT COX; Fiscal Year: 2005
    ..processes to produce sufficient quantities of the modified B-interferon proteins for testing in animal disease models. In a clinical setting, the improved characteristics of the novel B-interferon proteins may reduce the ..
  12. High-resolution tomography for small animal imaging
    CHARLES KEVIN GARY; Fiscal Year: 2007
    ..will be a table-top computerized tomographic imaging system for use in research laboratories using small animal disease models with per frame exposure times of a few seconds...
  13. ASN Workshop "In Vivo MR Tracking of Stem Cells in the CNS" (R13)
    Jeff W Bulte; Fiscal Year: 2005
    ..pursued as a very active research area over the last decade and a remarkable progress has been obtained in animal disease models. To further develop cell-based therapies into the clinic, noninvasive cellular imaging techniques are ..
  14. The ALS Gene Family of Candida albicans
    Lois L Hoyer; Fiscal Year: 2008
    ..albicans morphological forms, during cell mating, and on fungal cells from various animal disease models. We will also use the antibodies to support our conclusions about the role of Als proteins in C...
  15. Small Animal Imaging Core
    Jerry D Glickson; Fiscal Year: 2008
    ..Although both large and small animal disease models currently exist and are readily being developed for various human diseases, the use of small animals (e.g...
  16. Small Animal PET System
    Robert S Miyaoka; Fiscal Year: 2008
    ..to provide tissue quantitation of biologically specific radiopharmaceuticals required in small animal disease models. Imaging using PET radionuclides has become a remarkably useful translational tool for UW/FHCRC ..
  17. Small Animal Imaging Core
    Jerry D Glickson; Fiscal Year: 2007
    ..Although both large and small animal disease models currently exist and are readily being developed for various human diseases, the use of small animals (e.g...
  18. A Unified Reporter Gene for Multi-Modality Imaging
    Jianghong Rao; Fiscal Year: 2005
    ..Such a versatile system should find wide applications in biology from in vivo cell trafficking, tumor metastasis, small animal disease models, transgenic mice, drug screenings in mice, to in vivo gene function and regulation study.
  19. Imaging Calpain/Bioenergetic Interactions in Neuronal Excitotoxicity
    Brian M Polster; Fiscal Year: 2007
    ..Although calpain inhibitors have shown early promise in small animal disease models, very little is known about the targets of calpain proteases and whether calpains contribute to ..
  20. Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism
    JAY JIE QIANG WU; Fiscal Year: 2008
    ..here is to develop more potent derivatives of VMD-C620 and study them in preclinical pharmacokinetic and animal disease models relevant to alcohol use disorders...
  21. Preclinical Development of Selective PKC_epsilon Inhibitors to Treat Alcoholism
    JAY JIE QIANG WU; Fiscal Year: 2007
    ..here is to develop more potent derivatives of VMD-C620 and study them in preclinical pharmacokinetic and animal disease models relevant to alcohol use disorders...
  22. Peptide Inhibitor For Alzheimer's Disease Therapy
    YAO-ZHONG LIN; Fiscal Year: 2004
    ..studying and manipulating a wide range of intracellular processes, both in vitro and in vivo, including animal disease models. In Specific Aim 1, we will examine whether imported Bsecretase substrate peptides can inhibit the ..
  23. Developing animal models for diseases using RNAi
    Zuoshang Xu; Fiscal Year: 2005
    ..Therefore, whether RNAi can serve as an alternative to gene knockout technology to generate animal disease models and to investigate molecular pathways in vivo is unclear...
  24. CORE--FUNCTIONAL GENOMICS
    Yi Zhou; Fiscal Year: 2008
    ..2. Apply bioinformatics tools to find gene regulation networks in animal disease models and human patient samples. 3. Map mutant genes and develop a reverse genetic strategy for zebrafish. ..
  25. CORE--FUNCTIONAL GENOMICS
    Yi Zhou; Fiscal Year: 2007
    ..2. Apply bioinformatics tools to find gene regulation networks in animal disease models and human patient samples. 3. Map mutant genes and develop a reverse genetic strategy for zebrafish.
  26. PLACENTAL PROTEIN 14 AS A UNIQUE IMMUNOREGULATOR
    Mark L Tykocinski; Fiscal Year: 2005
    ..by PP14; and 3) to design recombinant derivatives of PP14 with enhanced functions, and to explore their therapeutic use in autoimmune and alloimmune animal disease models. The proposed studies combine basic and applied features.

Publications63

  1. Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease
    Takao Yasuhara
    Department of Neurological Surgery, Okayama University, Graduate School of Medicine and Dentistry, Okayama, Japan
    Eur J Neurosci 19:1494-504
    ..Further, VEGF is likely to promote neuroprotection indirectly by activating the proliferation of glia and by promoting angiogenesis. Our results support a potential neuroprotective role for VEGF in the treatment of Parkinson's disease...
  2. Role of tumor necrosis factor-alpha in methamphetamine-induced drug dependence and neurotoxicity
    Akira Nakajima
    Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya 466 8560, Japan
    J Neurosci 24:2212-25
    ....
  3. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination
    Tara Karnezis
    Neuroimmunology Laboratory, Department of Biochemistry, School of Molecular Sciences, La Trobe University, Bundoora, Victoria 3086, Australia
    Nat Neurosci 7:736-44
    ..Our finding that Nogo A is involved in CNS autoimmune demyelination indicates that this molecule may have a far more complex role than has been previously anticipated...
  4. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833
    Garth T Whiteside
    Purdue Pharma Discovery Research, 6 Cedar Brook Drive, Cranbury, NJ 08512, USA
    Eur J Pharmacol 528:65-72
    ..Furthermore, these data suggest that the mechanism of action for GW405833 does not depend on the release of endogenous opioids...
  5. Responses of transgenic mouse lines p53(+/-) and Tg.AC to agents tested in conventional carcinogenicity bioassays
    J W Spalding
    National Institute of Environmental Health Sciences, Laboratory of Environmental Carcinogenesis and Mutagenesis, Research Triangle Park, North Carolina 27709, USA
    Toxicol Sci 53:213-23
    ..AC model (lauric acid diethanolamine and pentachlorophenol). These results show that these transgenic models do not respond to many chemicals that show strain- or species-specific responses in conventional bioassays...
  6. Opposing effects of cyclooxygenase-2 selective inhibitors on oxygen-glucose deprivation-induced neurotoxicity
    Tania F Gendron
    Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada K1H 8M5
    Eur J Pharmacol 493:45-55
    ..These results may account for the discrepancies among previous studies which used different inhibitors and different models of neurotoxicity...
  7. Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline
    Sylvie Cornet
    IPSEN: Institut Henri Beaufour, 5 Avenue du Canada, 91966 Les Ulis, France
    Eur J Pharmacol 505:111-9
    ..From these experiments, the neuroprotective activity of minocycline appears more related to its antiinflammatory activity than to a direct beneficial action on mitochondria...
  8. Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice
    Michael Schroeter
    Department of Neurology, Heinrich-Heine-University, Moorenstrasse 5, D-40225 Düsseldorf, Germany
    Brain Res Mol Brain Res 117:1-7
    ..Taken together, our study demonstrates considerable species differences in inflammatory gene induction after focal brain ischemia...
  9. Dual effect of local application of nitric oxide donors in a model of incision pain in rats
    Wiliam A Prado
    Department of Pharmacology, Faculty of Medicine of Ribeirão Preto USP, Av Bandeirantes 3900, CEP 14049 900, Ribeirão Preto, São Paolo, Brazil
    Eur J Pharmacol 441:57-65
    ..Drugs generating high NO concentrations, however, intensify pain via a guanylate cyclase-independent mechanism...
  10. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies
    Richard Kirsch
    Department of Anatomical Pathology, University of Cape Town, Cape Town, Western Cape, South Africa
    J Gastroenterol Hepatol 18:1272-82
    ..Of the groups studied, male C57/BL6 mice develop the most inflammation and necrosis, lipid peroxidation, and ultrastructural injury, and best approximate the histological features of NASH...
  11. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease
    J F Poduslo
    Molecular Neurobiology Laboratory, Department of Neurlogy, Mayo Clinic and Foundation, Rochester, Minnesota, 55905, USA
    Neurobiol Dis 8:555-67
    ..Although these observations suggest structural alterations at the BBB, they do not support the concept of extensive BBB damage with substantial increases in BBB permeability in Alzheimer's disease...
  12. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo
    Chrishan S Samuel
    Howard Florey Institute, Gate 11, University of Melbourne, Parkville, Victoria 3010, Australia edu au
    Endocrinology 145:4125-33
    ..01). These coherent findings indicate that relaxin regulates fibroblast proliferation, differentiation, and collagen deposition and may have therapeutic potential in diseased states characterized by cardiac fibrosis...
  13. Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures
    Gianni Bregola
    Department of Clinical and Experimental Medicine, Section of Pharmacology, University of Ferrara, 44100 Ferrara, Italy
    J Neurosci 22:10030-8
    ....
  14. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent
    Manuel Yepes
    Department of Vascular Biology, American Red Cross Holland Laboratory, Rockville, Maryland 20855, USA
    J Clin Invest 109:1571-8
    ..These findings indicate that tPA acts on a substrate other than plasminogen and that the effects of neuroserpin on seizure progression and neuronal cell survival are mediated through the inhibition of tPA...
  15. Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance
    Massimo Rizzi
    Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milano, Italy
    J Neurosci 22:5833-9
    ..P-gp alterations significantly affect antiepileptic drugs concentrations in the brain, suggesting that seizure-induced mdr mRNA expression contributes to MDR in epilepsy...
  16. In vivo lipid-derived free radical formation by NADPH oxidase in acute lung injury induced by lipopolysaccharide: a model for ARDS
    Keizo Sato
    Free Radical Metabolite Section, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA
    FASEB J 16:1713-20
    ..Rats treated intratracheally with LPS generate lipid-derived free radicals via activation of NADPH oxidase...
  17. Neurotrophic signaling in normal and degenerating rodent retinas
    K J Wahlin
    Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287 9277, USA
    Exp Eye Res 73:693-701
    ..These data add to the mounting evidence suggesting that neurotrophic factors act indirectly through Müller cells to promote photoreceptor survival...
  18. Animal models of nonalcoholic fatty liver disease and steatohepatitis
    Amin A Nanji
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Clin Liver Dis 8:559-74, ix
    ..The purpose of this article is to update information regarding animal models in the pathogenesis of NAFLD...
  19. Nuclear translocation of apoptosis-inducing factor after focal cerebral ischemia
    Nikolaus Plesnila
    Laboratory of Experimental Neurosurgery, Institute for Surgical Research, University of Munich, Germany
    J Cereb Blood Flow Metab 24:458-66
    ....
  20. Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease
    Soon-Won Park
    Department of Biochemistry, College of Medicine, Pusan National University, Busan 602-739, South Korea
    Neurosci Lett 363:243-6
    ..Therefore, these results suggest that NAC and OTC can be used as potential agents to prevent the progression of PD...
  21. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist
    Maureen Mullarkey
    Biology Section, Eisai Research Institute of Boston, Inc, Andover, Massachusetts, USA
    J Pharmacol Exp Ther 304:1093-102
    ..These results indicate that E5564 is a potent antagonist of LPS and lacks agonistic activity in human and animal model systems, making it a potentially effective therapeutic agent for treatment of disease states caused by endotoxin...
  22. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide
    C Culmsee
    Laboratory of Neurosciences, National Institute on Aging Gerontology Research Center, Baltimore 21224, USA
    J Neurochem 77:220-8
    ....
  23. An animal model of generalized nonconvulsive status epilepticus: immediate characteristics and long-term effects
    Michael Wong
    Department of Neurology and the Center for the Study of Nervous System Injury, Washington University School of Medicine, St Louis, MO 63110, USA
    Exp Neurol 183:87-99
    ..These results indicate that an animal model of GNCSE can be generated and that even in the absence of overt neuronal damage, GNCSE may produce functional changes in neurons that alter electrical excitability of neural circuits...
  24. Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models
    Ranjan Chakrabarti
    Discovery Biology, Dr Reddy's Laboratories-Discovery Research, Bollaram Road, Miyapur, Hyderabad 500 050, India
    Br J Pharmacol 140:527-37
    ..In these hyperlipidaemic animal models, PPARgamma ligands failed to show any significant efficacy. Taken together, ragaglitazar shows better insulin-sensitizing and lipid-lowering potential, as compared to the standard compounds...
  25. Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson's disease
    Tracey K Murray
    Eli Lilly and Co Ltd, Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey GU20 6PH, UK
    Eur J Pharmacol 486:163-74
    ..Therefore, we propose that AMPA receptor potentiators offer the potential of a new therapy to halt the progression and perhaps repair the degeneration in Parkinson's disease...
  26. Nicotinamide prevents N-methyl-N-nitrosourea-induced photoreceptor cell apoptosis in Sprague-Dawley rats and C57BL mice
    Katsuji Kiuchi
    Department of Pathology, Kansai Medical University, Moriguchi, Osaka 570-8506, Japan
    Exp Eye Res 74:383-92
    ..Although the mechanism of action underlying this retinoprotection remains to be clarified, NAM may be a potential therapeutic agent for the treatment of retinal degeneration...
  27. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke
    Margaret A Petty
    Systems Pharmacology, Mail Stop 303A, Aventis Pharmaceuticals Inc, Route 202 206, PO Box 6800, Bridgewater, NJ 08807, USA
    Eur J Pharmacol 474:53-62
    ..v., 5 min after occlusion; 30 mg/kg, s.c., 1 and 4 h post-middle cerebral artery occlusion) decreased infarct size by 42%. The consistent anti-ischemic effects of ACEA 1021 make it a valuable compound for exploratory stroke research...
  28. Evaluation of antinociceptive, anti-inflammatory and antipyretic effects of Strobilanthes cusia leaf extract in male mice and rats
    Yu-Ling Ho
    Institute of Chinese Pharmaceutical Sciences, China Medical College, Taichung 404, Taiwan, ROC
    Am J Chin Med 31:61-9
    ..It also reduced the paw edema induced by carrageenan in rats. In addition, it potently attenuated pyrexia induced by lipopolysaccharide...
  29. Microglia-Müller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration
    Takayuki Harada
    Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187 8502
    J Neurosci 22:9228-36
    ..These observations suggest that microglia regulate the microglia-Müller glia-photoreceptor network that serves as a trophic factor-controlling system during retinal degeneration...
  30. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety
    Chris S Busse
    Merck Research Laboratories, San Diego, CA, USA
    Neuropsychopharmacology 29:1971-9
    ....
  31. Role of cytochrome P450 1A2 in bilirubin degradation Studies in Cyp1a2 (-/-) mutant mice
    C Zaccaro
    Department of Pharmacology, University of Turin Medical School, Via P Giuria 13, 10125, Turin, Italy
    Biochem Pharmacol 61:843-9
    ..TCB was required for bilirubin degradation by CYP1A1. Manipulation of CYP1A2 may be of therapeutic benefit in patients with these diseases of bilirubin conjugation...
  32. [Experimental animal models of primary hyperparathyroidism]
    Yasuo Imanishi
    Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine
    Nippon Rinsho 63:292-9
  33. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy
    E Carro
    Laboratory of Neuroendocrinology, Cajal Institute, Consejo Superior de Investigaciones Cientificas, 28002 Madrid, Spain
    J Neurosci 21:5678-84
    ..These findings also support the use of IGF-I as a therapeutical aid in brain diseases coursing with either acute or progressive neuronal death...
  34. Brain mitochondrial uncoupling protein 2 (UCP2): a protective stress signal in neuronal injury
    Ingo Bechmann
    Department of Anatomy and Cell Biology, Humboldt University, Charite, Berlin, Germany
    Biochem Pharmacol 64:363-7
    ....
  35. A novel role for protein tyrosine phosphatase shp1 in controlling glial activation in the normal and injured nervous system
    A Horvat
    Department of Neuromorphology, Max Planck Institute of Neurobiology, D 82152 Martinsried, Germany
    J Neurosci 21:865-74
    ..These results emphasize that SHP1 as a part of different signaling pathways plays an important role in the global regulation of astrocytic and microglial activation in the normal and injured CNS...
  36. Asymmetrically lesioned mesencephalon in healthy rodents: call for caution
    Elsa Y Pioli
    Basal Gang, Laboratoire de Physiologie et Physiopathologie de la Signalisation Cellulaire, CNRS UMR 5543, Université Victor Segalen, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France
    Brain Res 1022:251-3
    ..This potential bias in assessing extent of neurotoxin-induced lesion and subsequent protection by pharmacological manipulation prompts us to call for caution in setting up experimental designs...
  37. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant
    G B Mackensen
    Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Neurosci 21:4582-92
    ..This was associated with decreased postischemic superoxide-mediated oxidative stress...
  38. VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting
    Seung Hahm
    Fishberg Research Center for Neurobiology, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Neurosci 22:6929-38
    ....
  39. Long-acting forms of Sonic hedgehog with improved pharmacokinetic and pharmacodynamic properties are efficacious in a nerve injury model
    R Blake Pepinsky
    Biogen, Inc, 14 Cambridge Center, Cambridge, Massachusetts 02142, USA
    J Pharm Sci 91:371-87
    ..These studies demonstrate that targeted PEGylation greatly alters the pharmacokinetic and pharmacodynamic properties of Shh, resulting in a form with improved pharmaceutical properties...
  40. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment
    Dominique Deplanque
    Laboratoire de Pharmacologie, Université de Lille 2, Faculté deMédecine, Lille, 59045 France
    J Neurosci 23:6264-71
    ....
  41. Ventilation-induced activation of the mitogen-activated protein kinase pathway
    U Uhlig
    Division of Pulmonary Pharmacology, Research Center Borstel, Germany
    Eur Respir J 20:946-56
    ....
  42. In a transgenic model of spontaneous autoimmune diabetes, expression of a protective class II MHC molecule results in thymic deletion of diabetogenic CD8+ T cells
    David J Morgan
    University of Bristol, School of Medical Sciences, Bristol, United Kingdom
    J Immunol 172:1000-8
    ....
  43. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis
    Masataka Sata
    Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    Nat Med 8:403-9
    ....
  44. Comparison of the levels of enzymes involved in drug metabolism between transgenic or gene-knockout and the parental mice
    N Ariyoshi
    Laboratory of Drug Metabolism, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
    Toxicol Pathol 29:161-72
    ..The content or activities of almost all other enzymes examined in the present study do not appear to be affected by the gene manipulation...
  45. Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization
    H Ma
    Department of Oral Molecular Biology, Oregon Health and Science University, Portland, Oregon 97201, USA
    J Biol Chem 276:28525-31
    ..In conclusion, calpain 10 seems to be a ubiquitous calpain, the expression level and subcellular distribution of which are dynamically influenced by calcium...
  46. Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage
    Godwin Okoye
    Department of Ophthalmology, Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 9277, USA
    J Neurosci 23:4164-72
    ..Double transgenic mice with inducible expression of survival factors provide valuable tools for selection of survival factor candidates for gene therapy...
  47. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia
    Sang Won Suh
    Department of Neurolog, University of California, San Francisco, California 94143, USA
    J Neurosci 23:10681-90
    ..These results suggest that PARP-1 activation is a major factor mediating hypoglycemic neuronal death and that PARP-1 inhibitors can rescue neurons that would otherwise die after severe hypoglycemia...
  48. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo
    Shigeru Ueshima
    Department of Physiology, Kinki University School of Medicine, Osakasayama, Osaka, Japan
    Thromb Haemost 87:1069-74
    ..Thus, a newly synthesized compound, JTV-926 induced t-PA release from vascular endothelial cells and effective thrombolysis in vivo...
  49. Antidiarrhoeal activity of hot water extract of black tea (Camellia sinensis)
    S E Besra
    Division of Pharmacology and Experimental Therapeutics, Indian Institute of Chemical Biology, 4 Raja S C Mullick Road, Calcutta 700032, India
    Phytother Res 17:380-4
    ..Naloxone (0.5 mg/kg i.p.) significantly inhibited the antidiarrhoeal activity of the extract as well as loperamide, thus indicating a role of the opioid system in the antidiarrhoeal activity of the extract...
  50. alpha-Spinasterol isolated from the root of Phytolacca americana and its pharmacological property on diabetic nephropathy
    Seung I Jeong
    Department of Pharmacology, Wonkwang University School of Medicine, Jeonbuk, Korea
    Planta Med 70:736-9
    ..Therefore, the results obtained in this study suggest that alpha-spinasterol has a significant therapeutic potential to modulate the development and/or progression of diabetic nephropathy...
  51. Attenuation of internal organ damages by exogenously administered epidermal growth factor (EGF) in burned rodents
    Jorge Berlanga
    Center for Genetic Engineering and Biotechnology, P O Box 6162, 10600, Havana, Cuba
    Burns 28:435-42
    ..These data indicate the salutary effects of EGF by attenuating internal complications associated to thermal injuries. Further studies are warranted to fully elucidate the usefulness of this therapy...
  52. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis
    U Christen
    Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA 92037, USA
    J Immunol 166:7023-32
    ..This observation has importance for understanding the complex role of inflammatory cytokines in autoimmunity...
  53. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis
    J M Spergel
    Division of Immunology, Children s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Invest 103:1103-11
    ..These results suggest that both the TH2 cytokines IL-4 and IL-5 and the TH1 cytokine IFN-gamma play important roles in the inflammation and hypertrophy of the skin in AD...
  54. Endothelial lipase is synthesized by hepatic and aorta endothelial cells and its expression is altered in apoE-deficient mice
    Kenneth C W Yu
    School of Medicine, Stanford University, Palo Alto, CA, USA
    J Lipid Res 45:1614-23
    ..In the aorta, EL was higher in EKO than in wild-type mice, and cholesterol feeding had no effect. Together, these data suggest that EL may be upregulated at the site of atherosclerotic lesions and thus could supply lipids to the area...
  55. Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat
    Jacintha M Shenton
    Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    Chem Res Toxicol 16:1078-89
    ..Therefore, it may represent a good animal model for the study of idiosyncratic drug reactions...
  56. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo
    Da-Wei Li
    Natural Products Research Institute, College of Pharmacy, Seoul National University, 28 Yeonkun-Dong, Jongno-Ku, Seoul 110-460, South Korea
    Thromb Res 113:67-73
    ..One possible mechanism may result from AS-thrombin interaction...
  57. Functional blockade of platelet-derived growth factor receptor-beta but not of receptor-alpha prevents vascular smooth muscle cell accumulation in fibrous cap lesions in apolipoprotein E-deficient mice
    H Sano
    Departments of Geriatric Medicine, Graduate School of Medicine, Kyoto University, Japan
    Circulation 103:2955-60
    ..CONCLUSIONS: These results indicate that PDGFR-beta plays a significant role in formation of fibrous atherosclerotic lesions and that regulation of the signal transduction through PDGFR-beta could affect atherogenesis in mice...
  58. Cloning of rodent megsin revealed its up-regulation in mesangioproliferative nephritis
    M Nangaku
    Molecular and Cellular Nephrology, Institute of Medical Sciences Tokai University School of Medicine, Kanagawa, Japan
    Kidney Int 60:641-52
    ....
  59. Cell transplantation in wounded mixed connective tissues
    Pedrag Charles Lekic
    Faculty of Dentistry, University of Manitoba, Manitoba, Canada
    Anat Rec A Discov Mol Cell Evol Biol 287:1256-63
    ....